Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mind Medicine Mindmed Inc (NQ: MNMD ) 6.360 -0.060 (-0.93%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Mind Medicine Mindmed Inc < Previous 1 2 3 4 5 Next > FCM Concerned MindMed’s Mismanagement Threatens Mental Health for Millions May 25, 2023 From Concerned Shareholders of Company MindMed Via GlobeNewswire MindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and Shareholders May 25, 2023 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed Publishes Report by Leading FDA Experts Validating MindMed’s MM-120 Drug Development Strategy May 25, 2023 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed to Present Data on the Preclinical Activity of MM-402 at the American Society of Clinical Psychopharmacology (ASCP) 2023 Annual Meeting May 24, 2023 From MindMed Via Business Wire MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD) May 17, 2023 From MindMed Via Business Wire FCM Director Nominees Will Put MindMed Drug Development Process Back on Track May 15, 2023 From Concerned Shareholders of Company MindMed Via GlobeNewswire FCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management’s Track Record of Shareholder Value Destruction May 05, 2023 From Concerned Shareholders of Company MindMed Via GlobeNewswire MindMed Reports First Quarter 2023 Financial Results and Business Highlights May 04, 2023 From MindMed Via Business Wire MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy May 02, 2023 From MindMed Via Business Wire MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update May 01, 2023 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed to Participate in May Investor Conferences April 26, 2023 From MindMed Via Business Wire FCM Nominates Exceptional Director Candidates to Restore MindMed’s Value April 21, 2023 From Concerned Shareholders of Company MindMed Via GlobeNewswire MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting April 18, 2023 From MindMed Via Business Wire MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD) April 14, 2023 From MindMed Via Business Wire MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary April 13, 2023 From MindMed Via Business Wire MindMed Reports Full Year 2022 Financial Results and Business Highlights March 09, 2023 From MindMed Via Business Wire MindMed to Participate in March Investor Conferences February 28, 2023 From MindMed Via Business Wire Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry January 26, 2023 EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END Via FinancialNewsMedia Topics Economy Exposures Supply Chain Three Trends That May Shape the Psychedelics Industry Next Year January 03, 2023 Via Investor Brand Network Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls November 14, 2022 From Concerned Shareholders of Company MindMed Via GlobeNewswire Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct November 03, 2022 From Concerned Shareholders of Company MindMed Via GlobeNewswire Psychedelic Drugs Prove Their Worth In Clinical Trials October 11, 2022 Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial... Via PressReach Colorado to Vote on Legalizing Psychoactives in November October 05, 2022 Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the... Via PressReach Topics Supply Chain Exposures Supply Chain Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics September 22, 2022 Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... Via PressReach Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics September 22, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... Via FinancialNewsMedia Psychedelics May Make People Less Afraid of Death September 07, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change... Via FinancialNewsMedia Topics Supply Chain Exposures Supply Chain Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity August 18, 2022 Via Investor Brand Network Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression August 10, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... Via FinancialNewsMedia Topics Supply Chain Exposures Supply Chain World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health June 15, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a... Via FinancialNewsMedia Oregon to Become the First State to Legally Roll Out Psilocybin April 28, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in... Via FinancialNewsMedia Topics Derivatives ETFs Exposures Derivatives < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.